Literature DB >> 20941453

Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib.

Zaverio M Ruggeri1, Alessandro Zarpellon, James R Roberts, Richard A Mc Clintock, Hua Jing, G Loredana Mendolicchio.   

Abstract

The main question concerning the mechanism of a-thrombin binding to platelet membrane glycoprotein (GP)Ib is whether it involves both thrombin exosite I and exosite II. The solution of two independent crystal structures suggests alternative explanations that may actually reflect different modes of binding with distinct pathophysiological significance. With respect to function, it is still unclear whether thrombin binding to GPIb promotes procoagulant and prothrombotic pathways of response to vascular injury or limits such responses by sequestering, at least temporarily, the active enzyme. We review here published information on these topics and touch upon ongoing studies aimed at finding definitive answers to outstanding questions relevant for a better understanding of thrombosis and haemostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20941453      PMCID: PMC3810535          DOI: 10.1160/TH10-09-0578

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  66 in total

1.  Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation.

Authors:  H N Bradford; R A Pixley; R W Colman
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

2.  Platelet glycoprotein Ib alpha binds to thrombin anion-binding exosite II inducing allosteric changes in the activity of thrombin.

Authors:  C Q Li; A Vindigni; J E Sadler; M R Wardell
Journal:  J Biol Chem       Date:  2000-10-09       Impact factor: 5.157

3.  The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity.

Authors:  D Dörmann; K J Clemetson; B E Kehrel
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

Review 4.  Platelets in atherothrombosis.

Authors:  Zaverio M Ruggeri
Journal:  Nat Med       Date:  2002-11       Impact factor: 53.440

Review 5.  Are thrombocytes and platelets true phagocytes?

Authors:  José Meseguer; M Angeles Esteban; Alejandro Rodríguez
Journal:  Microsc Res Tech       Date:  2002-06-15       Impact factor: 2.769

6.  Interaction of the 268-282 region of glycoprotein Ibalpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII.

Authors:  R De Cristofaro; V De Filippis
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

7.  Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib.

Authors:  R De Cristofaro; E De Candia; R Landolfi; S Rutella; S W Hall
Journal:  Biochemistry       Date:  2001-11-06       Impact factor: 3.162

8.  Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation.

Authors:  Sarah Uff; Jeannine M Clemetson; Tim Harrison; Kenneth J Clemetson; Jonas Emsley
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

9.  Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain.

Authors:  Eric G Huizinga; Shizuko Tsuji; Roland A P Romijn; Marion E Schiphorst; Philip G de Groot; Jan J Sixma; Piet Gros
Journal:  Science       Date:  2002-08-16       Impact factor: 47.728

10.  Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18).

Authors:  D I Simon; Z Chen; H Xu; C Q Li; J f Dong; L V McIntire; C M Ballantyne; L Zhang; M I Furman; M C Berndt; J A López
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

View more
  13 in total

1.  Binding of alpha-thrombin to surface-anchored platelet glycoprotein Ib(alpha) sulfotyrosines through a two-site mechanism involving exosite I.

Authors:  Alessandro Zarpellon; Reha Celikel; James R Roberts; Richard A McClintock; G Loredana Mendolicchio; Kevin L Moore; Hua Jing; Kottayil I Varughese; Zaverio M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

Review 2.  Historical perspective and future directions in platelet research.

Authors:  B S Coller
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

Review 3.  Platelet-neutrophil interactions under thromboinflammatory conditions.

Authors:  Jing Li; Kyungho Kim; Andrew Barazia; Alan Tseng; Jaehyung Cho
Journal:  Cell Mol Life Sci       Date:  2015-02-04       Impact factor: 9.261

4.  Genetic deletion of platelet glycoprotein Ib alpha but not its extracellular domain protects from atherosclerosis.

Authors:  E K Koltsova; P Sundd; A Zarpellon; H Ouyang; Z Mikulski; A Zampolli; Z M Ruggeri; K Ley
Journal:  Thromb Haemost       Date:  2014-08-07       Impact factor: 5.249

5.  Src family kinases inhibition by dasatinib blocks initial and subsequent platelet deposition on collagen under flow, but lacks efficacy with thrombin generation.

Authors:  Yiyuan Zhang; Scott L Diamond
Journal:  Thromb Res       Date:  2020-05-13       Impact factor: 3.944

6.  Signaling-mediated cooperativity between glycoprotein Ib-IX and protease-activated receptors in thrombin-induced platelet activation.

Authors:  Brian Estevez; Kyungho Kim; M Keegan Delaney; Aleksandra Stojanovic-Terpo; Bo Shen; Changgeng Ruan; Jaehyung Cho; Zaverio M Ruggeri; Xiaoping Du
Journal:  Blood       Date:  2015-11-19       Impact factor: 22.113

7.  Targeting the GPIbα binding site of thrombin to simultaneously induce dual anticoagulant and antiplatelet effects.

Authors:  Akul Y Mehta; Jay N Thakkar; Bassem M Mohammed; Erika J Martin; Donald F Brophy; Takao Kishimoto; Umesh R Desai
Journal:  J Med Chem       Date:  2014-03-25       Impact factor: 7.446

Review 8.  Platelets Are at the Nexus of Vascular Diseases.

Authors:  Héloïse Lebas; Katia Yahiaoui; Raphaël Martos; Yacine Boulaftali
Journal:  Front Cardiovasc Med       Date:  2019-09-11

9.  On the versatility of von Willebrand factor.

Authors:  Antoine Rauch; Nikolett Wohner; Olivier D Christophe; Cécile V Denis; Sophie Susen; Peter J Lenting
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-07-10       Impact factor: 2.576

10.  Incidence of Platelet Dysfunction by Thromboelastography-Platelet Mapping in Children Supported with ECMO: A Pilot Retrospective Study.

Authors:  Arun Saini; Mary E Hartman; Brian F Gage; Ahmed Said; Avihu Z Gazit; Pirooz Eghtesady; Umar S Boston; Philip C Spinella
Journal:  Front Pediatr       Date:  2016-01-06       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.